FOR ANIMAL TREATMENT ONLY

Do not use in pregnant or lactating bitches.

Following the first vaccination, it is very common for puppies to develop a small visible swelling (<2 cm) lasting for generally only two days. Following the second vaccination, it is very common for a small visible swelling (up to 5 cm) to be seen at the injection site, which may last for up to five days. The swelling may be painful for 1-2 days. In most cases these small and transient injection site reactions resolve with no need for treatment.

In very rare cases, type I hypersensitivity reactions (facial oedema, urticaria, anaphylactic reaction), vomiting and diarrhoea may be observed after vaccination. In the event of an allergic or anaphylactic reaction, immediate appropriate symptomatic treatment should be given.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.

Only healthy dogs should be vaccinated. The vaccine may not be effective in dogs incubating the disease at the time of vaccination.

No information is available on the safety and efficacy of the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccine should be administered within 14 days before or after vaccination with this product.

Animals that have received immunosuppressive drugs (eg glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed.

The live virus strains present in the vaccine may spread to unvaccinated animals, but do not cause disease.

The efficacy of the CDV, CPV and CAV components of the vaccine may be reduced due to maternal antibody interference. However, the vaccine has been proved to be of benefit against virulent challenge in the presence of maternal antibody levels to CDV, CAV and CPV that are likely to be encountered under field conditions. In situations where higher MDA levels are expected the vaccination protocol should be planned accordingly.

Not applicable.